Publications - Hastim
19 Jun 2024
APAVAC® autologous Vaccine Which indications for which animals ?
Marketed 10 years ago for canine lymphoma, as a "personalised" immunotherapy in adjuvant medical treatment to chemotherapy, APAVAC® has already been used to treat more than 1,000 animals. But other species and other indications have also benefited from this treatment.
27 Jul 2022
My publication
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications